QVT Financial’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $331M | Sell |
29,381,635
-36,412,144
| -55% | -$410M | 29.5% | 1 |
|
|
2025
Q1 | $664M | Hold |
65,793,779
| – | – | 61.12% | 1 |
|
|
2024
Q4 | $778M | Hold |
65,793,779
| – | – | 69.37% | 1 |
|
|
2024
Q3 | $759M | Sell |
65,793,779
-926,000
| -1% | -$10.7M | 65.34% | 1 |
|
|
2024
Q2 | $705M | Hold |
66,719,779
| – | – | 66.32% | 1 |
|
|
2024
Q1 | $703M | Sell |
66,719,779
-45,821,757
| -41% | -$483M | 59.48% | 1 |
|
|
2023
Q4 | $1.26B | Hold |
112,541,536
| – | – | 71.6% | 1 |
|
|
2023
Q3 | $1.31B | Sell |
112,541,536
-10,000,000
| -8% | -$117M | 74.33% | 1 |
|
|
2023
Q2 | $1.24B | Hold |
122,541,536
| – | – | 67.65% | 1 |
|
|
2023
Q1 | $904M | Hold |
122,541,536
| – | – | 44.47% | 1 |
|
|
2022
Q4 | $979M | Sell |
122,541,536
-6,852,281
| -5% | -$54.7M | 51.63% | 1 |
|
|
2022
Q3 | $417M | Hold |
129,393,817
| – | – | 29.07% | 1 |
|
|
2022
Q2 | $527M | Hold |
129,393,817
| – | – | 33.18% | 1 |
|
|
2022
Q1 | $639M | Hold |
129,393,817
| – | – | 27.73% | 2 |
|
|
2021
Q4 | $1.3B | Buy |
+129,393,817
| New | +$1.3B | 44.7% | 1 |
|